Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06299371
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-07
First Post:
2024-02-19
Brief Title:
Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations
Sponsor:
Liaoning Tumor Hospital Institute
Organization:
Liaoning Tumor Hospital Institute
Organization Data
Organization:
Liaoning Tumor Hospital Institute
Class:
OTHER
Study ID:
MA-NSCLC-II-033
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Liaoning Tumor Hospital Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Hongxu Liu
Responsible Party Title:
Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Liaoning Tumor Hospital Institute
Old Name:
None
Old Organization:
None